“COVID-19 in Tralokinumab-Treated Patients With Moderate-to- Severe Atopic Dermatitis: Case Series from the ECZTEND Long- Term Extension Trial”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s58. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/1409.